New Zealand markets close in 17 minutes

Coya Therapeutics, Inc. (COYA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.30-0.59 (-6.64%)
At close: 04:00PM EDT
8.34 +0.04 (+0.48%)
After hours: 07:22PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
6,129
6,002
0
0
Operating expenses
Research development
7,408
5,502
4,412
2,542
Selling general and administrative
8,612
7,833
4,847
2,312
Total operating expenses
16,047
13,362
9,287
4,870
Operating income or loss
-9,918
-7,360
-9,287
-4,870
Interest expense
-
-
-
0
Total other income/expenses net
338.634
96.179
-2,958
-21.482
Income before tax
-9,579
-7,264
-12,245
-4,892
Income tax expense
-
723.852
0
-
Income from continuing operations
-10,303
-7,988
-12,245
-4,892
Net income
-10,303
-7,988
-12,245
-4,892
Net income available to common shareholders
-10,303
-7,988
-12,245
-4,892
Basic EPS
-1.24
-
-4.73
-0.74
Diluted EPS
-1.24
-
-4.73
-0.74
Basic average shares
9,948
-
2,590
6,603
Diluted average shares
9,948
-
2,590
6,603